No abstract available
Publication types
-
Letter
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Dose-Response Relationship, Drug
-
Female
-
Gastrointestinal Diseases / chemically induced*
-
Glucagon-Like Peptide 1 / adverse effects
-
Glucagon-Like Peptide 1 / analogs & derivatives*
-
Humans
-
Incretins / adverse effects*
-
Liraglutide
-
Male
-
Middle Aged
Substances
-
Incretins
-
Liraglutide
-
Glucagon-Like Peptide 1